Table 2. Demographic and clinical characteristics of those who had heard of HZ Vaccine and either did or did not receive HZ Vaccine

 

 

Received HZ Vaccine
n = 119, (%)

Did not receive HZ Vaccine
n = 300, (%)

P-Value; Odds Ratio [95% Confidence Interval]

Gender

 

 

 

P = 0.42

 

Male

45.7

37.9

 

 

 

 

Female

54.3

62.1

 

 

 

Age Group

 

 

 

 

 

 

 

50-59

0

17.2

 

 

 

 

60-69

17.1

25.3

 

 

 

 

≥70

82.9

57.5

≥70 years v. all other age groups:
P = 0.008; 3.54 [1.37-10.23]

Ethnicity

 

 

 

 

 

 

 

Caucasian

100

90.8

 

 

 

 

Hispanic

0

3.4

 

 

Black

0

5.7

 

 

 

 

 

Other

0

0

 

 

 

 

Highest level of Education

 

 

 

 

 

 

 

Grade school

0

0

 

 

 

 

 

Middle school

5.7

2.3

 

 

 

 

 

High school

40.0

31.0

 

 

 

 

 

College

37.1

51.7

College & post graduate v. all other education levels.  P = 0.19

 

Post graduate

17.1

14.9

 

 

 

Employment Status

 

 

 

 

 

 

Yes

11.4

25.3

 

 

 

 

No

11.4

18.4

 

 

 

 

Retired

77.1

56.3

Retired v. all other employment statuses:
P = .03; 2.59 [1.97-6.71]

Have health insurance

100.0

98.9

P = 0.52

Visited PCP in the past year

100.0

90.8

P = 0.02

Remember chicken pox

97.1

81.6

P = 0.02; 7.58 [4.27-9.73]

Heard of shingles

97.1

94.3

P = 0.50

Had shingles

26.4

34.7

P = 0.018; 0.76 [0.55-2.17]

Have blood relatives with shingles

37.1

31.0

P = 0.51

Have friends and/or spouse with shingles

42.9

47.1

P = 0.66

Received influenza vaccine in the past year

85.7

56.3

P = 0.002; 4.60 [1.70-14.48]

Reported adverse reaction to vaccine in the past

11.4

8.0

P = 0.55

Heard of HZ Vaccine

28.7

 

 

Informed of recent FDA approval of HZ Vaccine for adults ≥50 years of age

68.6

23.0

P = 0.000003; 7.16 [3.03-17.72]

Heard of HZ Vaccine from:

 

 

 

 

PCP

40.0

24.1

P = 0.023; 2.08 [0.88-4.84]

 

Dermatologist

22.9

12.6

P = 0.15

 

Pharmacy

5.7

3.4

 

 

News

20.0

40.2

 

 

Other

11.4

19.5